Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-09

COAG vs REPL: stock comparison and AI forecast

Hemab Therapeutics Holdings, Inc. (COAG) and Replimune Group, Inc. (REPL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

COAG Hemab Therapeutics Holdings, Inc.

Market Cap
$2.29B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

REPL Replimune Group, Inc.

Price
$21.62 +547.3% · 6M
Market Cap
$2.05B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

COAG · REPL

Key facts

  • COAG is 1.1 times larger than REPL by market capitalization ($2.29B against $2.05B).
  • REPL carries 0.83 times debt per unit of equity, against 0.03 times for COAG.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCOAGREPL
Market Cap$2.29B$2.05B
P/B Ratio5.04x10.01x
EPS–$-3.02
Book Value/Share$9.72$2.16
FCF/Share–$-2.56

Profitability & Margins

MetricCOAGREPL
ROE–-132.4%
ROA–-72.5%
ROIC–-82.1%
Tax Rate–0.2%

Financial Health

MetricCOAGREPL
Current Ratio35.85x7.11x
Quick Ratio–6.90x
D/E Ratio0.03x0.83x
Financial Leverage1.03x1.83x
Interest Coverage–-22.3x
Working Capital$451M$278M

Cash Flow

MetricCOAGREPL
Operating Cash Flow–-$246M
Free Cash Flow–-$243M
Capital Spending–$3M

Income Statement

MetricCOAGREPL
Operating Income–-$270M
Net Income–-$271M
R&D Expense–$189M

Dividend & Shareholder Information

MetricCOAGREPL
Shares Outstanding47M95M
FAQ

COAG vs REPL: stock comparison and AI forecast

Which is bigger, COAG or REPL?

COAG is 1.1 times larger than REPL by market capitalization ($2.29B against $2.05B).

Which one does Intratio's AI model rank higher, COAG or REPL?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.